RICCIARDI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 1.693
EU - Europa 702
AS - Asia 187
AF - Africa 1
Totale 2.583
Nazione #
US - Stati Uniti d'America 1.689
PL - Polonia 216
IT - Italia 136
IE - Irlanda 125
SE - Svezia 111
HK - Hong Kong 78
CN - Cina 45
RU - Federazione Russa 39
SG - Singapore 29
FI - Finlandia 28
JO - Giordania 25
DE - Germania 20
UA - Ucraina 15
VN - Vietnam 6
CA - Canada 4
GB - Regno Unito 4
NL - Olanda 3
BE - Belgio 2
JP - Giappone 2
PT - Portogallo 2
CH - Svizzera 1
IN - India 1
MU - Mauritius 1
TR - Turchia 1
Totale 2.583
Città #
Fairfield 299
Warsaw 216
Ashburn 155
Chandler 142
Woodbridge 142
Seattle 129
Dublin 125
Cambridge 118
Houston 117
Wilmington 90
Hong Kong 50
Ann Arbor 48
Jacksonville 43
Lawrence 42
Altamura 41
Princeton 34
Boston 27
Buffalo 26
San Diego 21
Beijing 20
Singapore 18
Boardman 14
Medford 12
Florence 10
Falls Church 9
Kent 9
New York 9
Norwalk 9
Shanghai 8
Milan 6
Cagliari 4
Dong Ket 4
Rome 4
West Jordan 4
Alba 3
Andover 3
Laurel 3
Brussels 2
Calcinaia 2
Campi Bisenzio 2
Cantagallo 2
Capergnanica 2
Cesena 2
Cosenza 2
Empoli 2
Guangzhou 2
Los Angeles 2
Orenburg 2
Phoenix 2
Pisa 2
Poggibonsi 2
Porto 2
Scarperia e San Piero 2
Terni 2
Toronto 2
Washington 2
Anzio 1
Avellino 1
Bern 1
Brescia 1
Chicago 1
Frankfurt Am Main 1
Leawood 1
Massa E Cozzile 1
Mcallen 1
Monte Di Procida 1
Montréal 1
Nave 1
Negrar 1
Parma 1
Philadelphia 1
Pune 1
Redwood City 1
Rotterdam 1
Saga 1
Saint Paul 1
Samarate 1
San Benedetto Del Tronto 1
Senago 1
Shenzhen 1
Stevenage 1
Tappahannock 1
Totale 2.078
Nome #
Predittori di efficacia dell’isolamento delle vene polmonari nel trattamento della fibrillazione atriale 192
Hemodynamic sensor in cardiac implantable electric devices: the endocardial accelaration technology 139
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 104
Effects of smoking in patients treated with cardiac resynchronization therapy 97
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. 92
Sleep Disordered Breathing and Arrhythmia Burden in Pacemaker Recipients 91
Left ventricular mass and progenitor cells in chronic heart failure patients 88
A contribution for validation of ECG criteria for interatrial conduction delay. 85
INSERTION OF A MAGNESIUM(II)-OCTACARBORANYL(HEXYLSULFANYL) PORPHYRAZINE 3 INTO LIPOSOMES: A PHYSICO-CHEMICAL STUDY 83
Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure 82
A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. 82
Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation 80
Simplified Selvester Score: a practical electrocardiographic instrument to predict response to CRT 79
Dual-site left ventricular cardiac resynchronization therapy. 78
Larger interventricular conduction time enhances mechanical response to resynchronization therapy 77
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. 77
Cardiac Resynchronization Therapy Acutely Improves Ventricular-Arterial Coupling by Reducing the Arterial Load: Assessment by Pressure-Volume Loops. 76
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 76
The influence of age on the psychological profile of patients with cardiac implantable electronic devices: results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association 74
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 73
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 73
Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. 73
Acute effects of His bundle pacing versus left ventricular and right ventricular pacing on left ventricular function. 73
Multicenter experience with implantable defibrillators subject to recall. 72
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. 70
Persistent atrial fibrillation in the elderly. A possible association with arterial stiffness, hyperuricemia and chronic inflammation 69
Atrial standstill disease progression documented after 13 years follow-up 68
Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy. 65
Which factors predict the behavior of ventricular extrasystoles in athletes over time? 64
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy 64
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 61
Role of natriuretic peptides in heart failure patients with special reference to those on cardiac resynchronization therapy 36
Totale 2.613
Categoria #
all - tutte 7.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020586 0 32 16 56 75 73 78 85 70 45 42 14
2020/2021308 30 36 17 31 14 24 17 37 27 38 16 21
2021/2022236 9 15 17 6 11 12 15 13 12 17 46 63
2022/2023597 55 141 35 32 33 92 84 40 58 4 17 6
2023/2024248 6 29 35 13 23 45 10 63 1 5 11 7
2024/202579 57 22 0 0 0 0 0 0 0 0 0 0
Totale 2.613